Ben-Maimon Carole
Larimar Therapeutics, Inc. · President and CEO
Ben-Maimon Carole is listed in public filings as director, officer: President and CEO. This Ben-Maimon Carole insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Larimar Therapeutics, Inc. (LRMR). Investors use Ben-Maimon Carole's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.2M600.6k shares | Grant / ExerciseJan 26, 2026 | $2.2M600.6k shares | $3.60 | -- | |
| --368.3k shares | Grant / ExerciseJan 26, 2026 | Disclosure amount unavailable100.1k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.9M546k shares | Grant / ExerciseJan 22, 2025 | $1.9M546k shares | $3.46 | -- | |
| --387.2k shares | Grant / ExerciseJan 22, 2025 | Disclosure amount unavailable91k shares | -- | -- |